Published in J Clin Invest on February 01, 1983
Secretion of immunoglobulins and plasma proteins from the jejunal mucosa. Transport rate and origin of polymeric immunoglobulin A. J Clin Invest (1984) 1.44
Clearance of circulating IgA immune complexes is mediated by a specific receptor on Kupffer cells in mice. J Exp Med (1984) 1.31
Metabolism of immunoglobulin E in patients with markedly elevated serum immunoglobulin E levels. J Clin Invest (1987) 1.08
Molecular heterogeneity of human IgA antibodies during an immune response. Clin Exp Immunol (1992) 1.08
Humoral immune response to influenza vaccination in patients with primary immunoglobulin A nephropathy. An analysis of isotype distribution and size of the influenza-specific antibodies. J Clin Invest (1989) 1.06
The N-glycans determine the differential blood clearance and hepatic uptake of human immunoglobulin (Ig)A1 and IgA2 isotypes. J Exp Med (2000) 1.06
Selective neutralization of a bacterial enterotoxin by serum immunoglobulin A in response to mucosal disease. Infect Immun (1995) 1.05
A polymeric IgA response in serum can be produced by parenteral immunization. Immunology (1987) 1.05
IgA1 and IgA2 immune complexes in primary IgA nephropathy and Henoch-Schönlein nephritis. Clin Exp Immunol (1984) 1.05
Kinetics of anti-Campylobacter jejuni monomeric and polymeric immunoglobulin A1 and A2 responses in serum during acute enteritis. J Clin Microbiol (1987) 1.05
The serum polymeric IgA antibody response to typhoid vaccination; its relationship to the intestinal IgA response. Immunology (1990) 0.96
IgA subclass antibodies to gliadin in serum and intestinal juice of patients with coeliac disease. Clin Exp Immunol (1990) 0.95
Hyper-immunoglobulin A in the hyperimmunoglobulinemia D syndrome. Clin Diagn Lab Immunol (2001) 0.93
Local IgA subclass alterations in ulcerative colitis and Crohn's disease of the colon. Gut (1987) 0.90
Serum levels and in vitro production of IgA subclasses in patients with primary IgA nephropathy. Clin Exp Immunol (1988) 0.89
Increased and prolonged production of specific polymeric IgA after systemic immunization with tetanus toxoid in IgA nephropathy. Clin Exp Immunol (1992) 0.88
Enumeration of IgA producing cells by the enzyme linked immunospot (ELISPOT) technique to evaluate sulphasalazine effects in inflammatory arthritides. Ann Rheum Dis (1991) 0.88
Gall bladder: the predominant source of bile IgA in man? Clin Exp Immunol (1985) 0.88
Induction of Fc receptors for IgA on murine T cell hybridoma by human monoclonal IgA and by high molecular weight IgA in IgA nephropathy. Clin Exp Immunol (1987) 0.87
Role of IgA and IgA fc receptors in inflammation. J Clin Immunol (2009) 0.87
Cellular origins of human polymeric and monomeric IgA: enumeration of single cells secreting polymeric IgA1 and IgA2 in peripheral blood, bone marrow, spleen, gingiva and synovial tissue. Clin Exp Immunol (1991) 0.85
Molecular size heterogeneity of immunoglobulins in health and disease. Clin Exp Immunol (1990) 0.84
Early impairment of gut mucosal immunity in HIV-1-infected children. Clin Exp Immunol (1994) 0.83
Association of liver cirrhosis related IgA nephropathy with portal hypertension. World J Gastroenterol (2007) 0.83
The polymeric immunoglobulin A receptor is present on hepatocytes in human liver. Immunology (1989) 0.83
Polyclonal B cell activation in alcoholic patients with no evidence of liver dysfunction. Clin Exp Immunol (1984) 0.83
Is there IgA of gut mucosal origin in the serum of HIV1 infected patients? Gut (1994) 0.81
Early detection of liver metastasis in patients with colorectal carcinoma by increased levels of circulating IgA- and IgM-associated secretory component. Br J Cancer (1987) 0.79
Alcohol inhibits lipopolysaccharide-induced tumor necrosis factor alpha gene expression by peripheral blood mononuclear cells as measured by reverse transcriptase PCR in situ hybridization. Clin Diagn Lab Immunol (1996) 0.79
A comparison of anti-HER2 IgA and IgG1 in vivo efficacy is facilitated by high N-glycan sialylation of the IgA. MAbs (2015) 0.78
IgA against gut-derived endotoxins: does it contribute to suppression of hepatic inflammation in alcohol-induced liver disease? Dig Dis Sci (2002) 0.78
Potential of immunoglobulin A to prevent allergic asthma. Clin Dev Immunol (2013) 0.78
Immunoglobulin A1 and A2 subclass of salivary antibodies to Candida albicans in patients with oral candidosis. Clin Exp Immunol (1988) 0.75
Critical Role of Kupffer Cell CD89 Expression in Experimental IgA Nephropathy. PLoS One (2016) 0.75
Contribution of secretory IgA, polymeric IgA and IgA/secretory component-containing circulating immune complexes to the serum hyper-IgA in diabetes mellitus. Diabetologia (1984) 0.75
Serologic assay for secretory component distinguishes mechanical from hepatocellular cholestasis in humans. Dig Dis Sci (1997) 0.75
Renal Outcomes in Patients With IgA Nephropathy Undergoing Liver Transplant: A Retrospective Cohort Study. Transplant Direct (2017) 0.75
The theory of tracer experiments with 131I-labelled plasma proteins. Phys Med Biol (1957) 7.66
SJOEGREN'S SYNDROME. A CLINICAL, PATHOLOGICAL, AND SEROLOGICAL STUDY OF SIXTY-TWO CASES. Medicine (Baltimore) (1965) 7.46
Metabolism of immunoglobulins. Prog Allergy (1969) 5.74
Rapid active transport of immunoglobulin A from blood to bile. J Exp Med (1978) 3.62
Structure and function of immunoglobulin A. Prog Allergy (1972) 3.14
A subclass of human gamma-A-globulins (gamma-A2) which lacks the disulfied bonds linking heavy and light chains. J Exp Med (1968) 2.98
The bone marrow: the major source of serum immunoglobulins, but still a neglected site of antibody formation. Clin Exp Immunol (1981) 2.54
Rapid disappearance from serum of intravenously injected rat myeloma IgA and its secretion into bile. Eur J Immunol (1978) 2.48
IgA subclasses in various secretions and in serum. Immunology (1982) 2.43
Comparative mapping of the local distribution of immunoglobulin-containing cells in ulcerative colitis and Crohn's disease of the colon. Clin Exp Immunol (1975) 2.40
Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus. J Clin Invest (1980) 2.11
Experimental IgA nephropathy. J Exp Med (1979) 2.09
Alterations of IgM, IgG, and IgA Synthesis and secretion by peripheral blood and intestinal mononuclear cells from patients with ulcerative colitis and Crohn's disease. Gastroenterology (1981) 1.98
High levels of secretory IgA and free secretory component in the serum of rats with bile duct obstruction. J Exp Med (1978) 1.91
Transport models for secretory IgA and secretory IgM. Clin Exp Immunol (1981) 1.90
Identification of secretory component as an IgA receptor on rat hepatocytes. J Exp Med (1979) 1.89
Selective transport of polymeric immunoglobulin A in bile. Quantitative relationships of monomeric and polymeric immunoglobulin A, immunoglobulin M, and other proteins in serum, bile, and saliva. J Clin Invest (1982) 1.84
Subclasses of human immunoglobulin a based on differences in the alpha polypeptide chains. Science (1966) 1.79
IgA glomerulonephritis (Berger's disease): evidence of high serum levels of polymeric IgA. Clin Exp Immunol (1980) 1.75
Subgroups of gamma-A immune globulins. Proc Soc Exp Biol Med (1966) 1.73
Tissue origins of human polymeric and monomeric IgA. J Immunol (1982) 1.73
Prevalence of IgA2 deposits in IgA nephropathies: a clue to their pathogenesis. N Engl J Med (1980) 1.67
Translocation of dimeric IgA through neoplastic colon cells in vitro. J Immunol (1979) 1.66
Two types of IgA immunocytes in man. Nat New Biol (1973) 1.65
Distribution of IgA 1 and IgA 2 plasma cells in various normal human tissues and in the jejunum of plasma IgA-deficient patients. Clin Exp Immunol (1978) 1.61
Isolation and description of a few properties of the beta 2A-globulin of human serum. Clin Chim Acta (1959) 1.60
Influence of molecular size of IgA on its immunoassay by various techniques. II. Solid-phase radioimmunoassays. J Immunol Methods (1982) 1.59
Serum immunoglobulins, complement component levels and autoantibodies in liver disease. Clin Exp Immunol (1973) 1.52
IGA in human bile and liver. J Immunol (1981) 1.50
Distribution of IgA subclasses in sera and bone marrow plasma cells of 21 normal individuals. Adv Exp Med Biol (1974) 1.48
In vivo and in vitro binding of IgA to the plasma membrane of hepatocytes. Scand J Immunol (1978) 1.47
Immunoglobulin metabolism in ataxia telangiectasia. J Clin Invest (1968) 1.38
Detection of monomeric and polymeric IgA containing immune complexes in serum and kidney from patients with alcoholic liver disease. Clin Exp Immunol (1982) 1.35
Properties of immunoglobulin A in serum of individuals with liver diseases and in hepatic bile. Gastroenterology (1982) 1.34
Ultrastructural events in the translocation of polymeric IgA by rat hepatocytes. J Immunol (1982) 1.33
Radioimmunoassay profile of antiglobulins in connective tissue diseases: elevated level of IgA antiglobulin in systemic sicca syndrome. Clin Exp Immunol (1981) 1.32
The membrane receptor for polymeric immunoglobulin is structurally related to secretory component. Isolation and characterization of membrane secretory component from rabbit liver and mammary gland. J Biol Chem (1981) 1.26
Immunoglobulin A and polymeric IgA rheumatoid factors in systemic sicca syndrome: partial characterization. J Immunol (1982) 1.25
Influence of molecular size of IgA on its immunoassay by various techniques--I. Direct and reversed single radial immunodiffusion. Mol Immunol (1982) 1.22
Bypass enteropathy. Intestinal and systemic manifestations following small-bowel bypass. JAMA (1976) 1.17
[Role of monomeric and dimeric immunoglobulin A in the hypergammaglobulinemia of alcoholic cirrhosis]. Biol Gastroenterol (Paris) (1977) 1.13
The origin of monomeric and polymeric forms of IgA in man. Adv Exp Med Biol (1974) 1.11
IgA in dermatitis-herpetiformis skin is dimeric. Lancet (1982) 1.11
Quantitation of exocrine IgA in human serum in health and disease. Clin Exp Immunol (1970) 1.08
Secretory component (SC): preferential binding to heavy (greater than 11S) IgA polymers and IgM in serum, in contrast to predominance of 11S and free SC forms in secretions. Clin Exp Immunol (1982) 1.06
A solid phase, direct competition, radioimmunoassay for quantitation of secretory IgA in human serum. J Immunol Methods (1981) 1.03
Immunoglobulins in rabbit hepatic bile: selective secretion of IgA and IgM and active plasma-to-bile transfer of polymeric IgA. Scand J Immunol (1982) 1.03
Analysis of circulating IgA and detection of immune complexes in primary IgA nephropathy. Clin Exp Immunol (1982) 1.02
Influence of molecular size of IgA on its immunoassay by various techniques. III. Immunonephelometry. J Immunol Methods (1982) 0.95
A comparative study of the biliary secretion of human dimeric and monomeric IgA in the rat and in man. Hepatology (1982) 0.94
High serum levels of secretory IgA in liver disease: possible liver origin of the circulating secretory component. Dig Dis Sci (1982) 0.94
Reassessment of levels of secretory IgA in pathological sera using a quantitative radioimmunoassay. Clin Exp Immunol (1981) 0.94
Hepatic function and protein metabolism in cirrhosis of the liver. Med Clin North Am (1955) 0.84
Serum IgM-bound secretory component (sIgM) in liver diseases: comparative molecular state of the secretory component in serum and bile. J Immunol (1982) 0.81
Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J (1993) 3.75
Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature (1991) 3.61
Cell damage-induced conformational changes of the pro-apoptotic protein Bak in vivo precede the onset of apoptosis. J Cell Biol (1999) 3.18
A mechanism for the induction of immunological tolerance by antigen feeding: antigen-antibody complexes. J Exp Med (1975) 2.59
Rapid disappearance from serum of intravenously injected rat myeloma IgA and its secretion into bile. Eur J Immunol (1978) 2.48
Rat bile as a convenient source of secretory IgA and free secretory component. Eur J Immunol (1977) 2.47
Protein A reactivity of various mammalian immunoglobulins. Scand J Immunol (1978) 2.43
IgA subclasses in various secretions and in serum. Immunology (1982) 2.43
Glutaraldehyde-activated aminohexyl- derivative of Sepharose 4B as a new verstile immunoabsorbent. Immunochemistry (1975) 2.42
The polymeric immunoglobulin receptor (secretory component) mediates transport of immune complexes across epithelial cells: a local defense function for IgA. Proc Natl Acad Sci U S A (1991) 2.02
Intravascular and mucosal immunoglobulin A: two separate but related systems of immune defense? Ann Intern Med (1987) 1.97
Hepatic [14C]aminopyrine demethylation capacity after portocaval shunting. Comparative study in patients with and without arterialization of portal vein. Dig Dis Sci (1993) 1.94
High levels of secretory IgA and free secretory component in the serum of rats with bile duct obstruction. J Exp Med (1978) 1.91
Mesenteric lymph as a major source of serum IgA in guinea pigs and rats. Eur J Immunol (1973) 1.90
Lung mucosal immunity: immunoglobulin-A revisited. Eur Respir J (2001) 1.87
Selective transport of polymeric immunoglobulin A in bile. Quantitative relationships of monomeric and polymeric immunoglobulin A, immunoglobulin M, and other proteins in serum, bile, and saliva. J Clin Invest (1982) 1.84
'Fit-for-purpose' validation of SearchLight multiplex ELISAs of angiogenesis for clinical trial use. J Immunol Methods (2009) 1.81
Requirement of basement membrane for the suppression of programmed cell death in mammary epithelium. J Cell Sci (1996) 1.80
Subclasses of human immunoglobulin a based on differences in the alpha polypeptide chains. Science (1966) 1.79
Origin and molecular size of immunoglobulin-A in the mesenteric lymph of the dog. Immunology (1970) 1.78
Biomarkers of angiogenesis and their role in the development of VEGF inhibitors. Br J Cancer (2009) 1.78
Epigenetic determinants of resistance to etoposide regulation of Bcl-X(L) and Bax by tumor microenvironmental factors. J Natl Cancer Inst (2000) 1.77
Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection. Infect Immun (1994) 1.68
Further studies on single radial immunodiffusion. II. The reversed system: diffusion of antibodies in antigen-containing gels. Immunochemistry (1969) 1.68
Nature and origin of the proteins of bile. I. A comparative analysis of serum and bile proteins in man. Eur J Clin Invest (1974) 1.59
Influence of molecular size of IgA on its immunoassay by various techniques. II. Solid-phase radioimmunoassays. J Immunol Methods (1982) 1.59
bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways. Cancer Res (1993) 1.59
Species-specific binding of human secretory component to SpsA protein of Streptococcus pneumoniae via a hexapeptide motif. Mol Microbiol (2000) 1.56
HLA association of amoxicillin-clavulanate--induced hepatitis. Gastroenterology (1999) 1.56
Relevance of biliary IgA antibodies in rat intestinal immunity. Scand J Immunol (1978) 1.53
Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study. Br J Cancer (2009) 1.50
A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker. Br J Cancer (2011) 1.50
Apoptosis and cancer chemotherapy. Trends Cell Biol (2001) 1.48
Secretion of immunoglobulins and plasma proteins from the jejunal mucosa. Transport rate and origin of polymeric immunoglobulin A. J Clin Invest (1984) 1.44
Oral immunization against cholera toxin with a live Yersinia enterocolitica carrier in mice. Gastroenterology (1992) 1.43
Lymphocyte cytotoxicity and inhibition studied with autologous liver cells: observations in chronic active liver disease and the primary biliary cirrhosis syndrome. Gastroenterology (1976) 1.43
Biomarker method validation in anticancer drug development. Br J Pharmacol (2007) 1.41
Pruritus associated with cholestatic liver disease. Ann Intern Med (1996) 1.40
Reduced epithelial expression of secretory component in small airways correlates with airflow obstruction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 1.39
Origin and nature of the proteins of bile. II. A comparative analysis of serum, hepatic lymph and bile proteins in the dog. Eur J Clin Invest (1974) 1.38
Validation of pharmacodynamic assays to evaluate the clinical efficacy of an antisense compound (AEG 35156) targeted to the X-linked inhibitor of apoptosis protein XIAP. Br J Cancer (2005) 1.36
A possible homologue of mammalian IgA in chicken serum and secretions. Immunology (1972) 1.35
Stimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardii. Dig Dis Sci (1990) 1.34
Damage-induced Bax N-terminal change, translocation to mitochondria and formation of Bax dimers/complexes occur regardless of cell fate. EMBO J (2001) 1.32
Optimisation of circulating biomarkers of cell death for routine clinical use. Ann Oncol (2008) 1.32
Hepatobiliary transport of plasma IgA in the mouse: contribution to clearance of intravascular IgA. Eur J Immunol (1985) 1.32
Altered patterns of secretion of monomeric IgA and IgA subclass 1 by intestinal mononuclear cells in inflammatory bowel disease. Gastroenterology (1986) 1.31
Serum and cystic fluid CA 19-9 determinations as a diagnostic help in liver cysts of uncertain nature. Liver (1996) 1.30
Eosinophilic gastroenteritis presenting with colitis and cholangitis. Dig Dis Sci (1995) 1.29
Proapoptotic Bid binds to monolysocardiolipin, a new molecular connection between mitochondrial membranes and cell death. Cell Death Differ (2003) 1.27
PCAF is an HIF-1alpha cofactor that regulates p53 transcriptional activity in hypoxia. Oncogene (2008) 1.26
Immunoglobulin A and polymeric IgA rheumatoid factors in systemic sicca syndrome: partial characterization. J Immunol (1982) 1.25
Extracellular matrix regulates apoptosis in mammary epithelium through a control on insulin signaling. J Cell Biol (1999) 1.24
Cellular damage signals promote sequential changes at the N-terminus and BH-1 domain of the pro-apoptotic protein Bak. Oncogene (2001) 1.23
On the significance of the heterogeneity in molecular size of human serum gamma A-globulins. Immunochemistry (1965) 1.23
Distribution of alpha-chain subclasses in normal and pathological IgA-globulins. Immunology (1968) 1.23
Influence of molecular size of IgA on its immunoassay by various techniques--I. Direct and reversed single radial immunodiffusion. Mol Immunol (1982) 1.22
Stimulation of transcytosis of the polymeric immunoglobulin receptor by dimeric IgA. Proc Natl Acad Sci U S A (1994) 1.21
Plasma infusions in immunologic deficiency states: metabolic and therapeutic studies. Blood (1966) 1.20
Effects of cisplatin on the induction of apoptosis in proliferating hepatoma cells and nonproliferating immature thymocytes. Cancer Res (1993) 1.20
Qualification of M30 and M65 ELISAs as surrogate biomarkers of cell death: long term antigen stability in cancer patient plasma. Cancer Chemother Pharmacol (2007) 1.19
In vivo experiments involving secretory component in the rat hepatic transfer of polymeric IgA from blood into bile. Immunology (1981) 1.18
Activated c-SRC in ductal carcinoma in situ correlates with high tumour grade, high proliferation and HER2 positivity. Br J Cancer (2006) 1.18
Reactivating HIF prolyl hydroxylases under hypoxia results in metabolic catastrophe and cell death. Oncogene (2009) 1.17
Cisplatin- and paclitaxel-induced apoptosis of ovarian carcinoma cells and the relationship between bax and bak up-regulation and the functional status of p53. Mol Pharmacol (1998) 1.17
Characterization of cell volume loss in CEM-C7A cells during dexamethasone-induced apoptosis. Am J Physiol (1996) 1.15
Oral immunization of mice with a live recombinant Yersinia enterocolitica O:9 strain that produces the cholera toxin B subunit. Infect Immun (1990) 1.15
Immune complexes in the aqueous humor and serum. Am J Ophthalmol (1977) 1.14
Multiple gene deletions within the human immunoglobulin heavy-chain cluster. Proc Natl Acad Sci U S A (1984) 1.13
Bid, a widely expressed proapoptotic protein of the Bcl-2 family, displays lipid transfer activity. Mol Cell Biol (2001) 1.13
Responses to treatment can differentiate chronic active liver disease with cholangitic features from the primary biliary cirrhosis syndrome. Gastroenterology (1976) 1.13
Current status and future potential of somatic mutation testing from circulating free DNA in patients with solid tumours. Hugo J (2011) 1.13
Characterization of an IgA receptor from group B streptococci: specificity for serum IgA. Eur J Immunol (1990) 1.12
High incidence of chromosome abnormalities in IgG3 myeloma. Cancer Genet Cytogenet (1984) 1.11
High proportion of polymeric IgA in young infants' sera and independence between IgA-size and IgA-subclass distributions. J Clin Immunol (1983) 1.09
Studies on the IgA system of the horse. Immunology (1971) 1.09
The SRC family protein tyrosine kinase p62yes controls polymeric IgA transcytosis in vivo. Mol Cell (1999) 1.09
Symptomatic myopathy in hepatitis C infection without interferon therapy. Lancet (1995) 1.08
Communications. Identification of IgA in several mammalian species. J Immunol (1969) 1.08
Fit-for-purpose biomarker method validation for application in clinical trials of anticancer drugs. Br J Cancer (2010) 1.08
Liver damage caused by therapeutic vitamin A administration: estimate of dose-related toxicity in 41 cases. Gastroenterology (1991) 1.07
Identification of J-chain in polymeric immunoglobulins from a variety of species by cross-reaction with rabbit antisera to human J-chain. J Immunol (1973) 1.07
Secretory component (SC): preferential binding to heavy (greater than 11S) IgA polymers and IgM in serum, in contrast to predominance of 11S and free SC forms in secretions. Clin Exp Immunol (1982) 1.06
Comparative molecular size of mouse IgA in different body fluids. Int Arch Allergy Appl Immunol (1970) 1.05